- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
June TOC Supplement
June Supplement TOC
Agency Confidential: The Scoop- What Your Agency Doesn't Want To Tell You
I've Seen The Revolution and It's Not Working
Elaine EisenPRESIDENT | CORBETT WORLDWIDE HEALTHCARE COMMUNICATIONS
Ahnal PurohitPRESIDENT AND CEO | PUROHIT NAVIGATION
Al TopinPRESIDENT | TOPIN and ASSOCIATES
Jon HudsonVICE PRESIDENT OF MEDIA AND DIGITAL SERVICES | MEDTHINK COMMUNICATIONS
Geoff MelickEVP/INTERACTIVE MARKETING and EINNOVATION | KINECT INTERACTIVE DIGITAL COMMUNICATIONS
Carleen KellyPRESIDENT | SURGE WORLDWIDE HEALTHCARE COMMUNICATIONS
Ross FetterolfVP OF DIGITAL STRATEGY | IGNITE HEALTHPharmaceuticals
Jeff BurkelCMO | MICROMASS COMMUNICATIONS
Joe DaleyPRESIDENT | GSW WORLDWIDE/US OPERATIONS
Didi DiscarPARTNER | MEDACCESS
Frank X. PowersEXECUTIVE VICE PRESIDENT | DUDNYK
Donna WrayMANAGEMENT ADVISOR, LEADER OF INTERNET AND RELATIONSHIP MARKETING PRACTICE | TGAS ADVISORS
Jay CarterSENIOR VICE PRESIDENT, DIRECTOR OF CLIENT SERVICES | ABELSONTAYLOR
Wendy BlackburnEXECUTIVE VICE PRESIDENT | INTOUCH SOLUTIONS
Kerry HiltonPRESIDENT AND CEO | HC and B HEALTHCARE COMMUNICATIONS
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
